Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-09

Clinical Trial Update: A Study of Bevacizumab (Avastin) in Combination With Chemotherapy in Participants With Metastatic Cancer of the Colon or Rectum [Phase 4]

View source ↗

Summary

This clinical trial update reports the results of a Phase 4 study of bevacizumab (Avastin) in combination with chemotherapy for metastatic colorectal cancer. Re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Avastin (bevacizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Colorectal Cancer | Phase 4 | Status: COMPLETED | Results posted: 2017-03-09